1. Home
  2. AMRX vs SHO Comparison

AMRX vs SHO Comparison

Compare AMRX & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • SHO
  • Stock Information
  • Founded
  • AMRX 2002
  • SHO 1995
  • Country
  • AMRX United States
  • SHO United States
  • Employees
  • AMRX N/A
  • SHO N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • SHO Hotels/Resorts
  • Sector
  • AMRX Health Care
  • SHO Consumer Discretionary
  • Exchange
  • AMRX Nasdaq
  • SHO Nasdaq
  • Market Cap
  • AMRX 2.5B
  • SHO 2.1B
  • IPO Year
  • AMRX N/A
  • SHO 1995
  • Fundamental
  • Price
  • AMRX $8.01
  • SHO $12.28
  • Analyst Decision
  • AMRX Strong Buy
  • SHO Hold
  • Analyst Count
  • AMRX 5
  • SHO 6
  • Target Price
  • AMRX $10.00
  • SHO $11.83
  • AVG Volume (30 Days)
  • AMRX 1.1M
  • SHO 3.5M
  • Earning Date
  • AMRX 11-08-2024
  • SHO 11-12-2024
  • Dividend Yield
  • AMRX N/A
  • SHO 2.92%
  • EPS Growth
  • AMRX N/A
  • SHO 89.56
  • EPS
  • AMRX N/A
  • SHO 0.76
  • Revenue
  • AMRX $2,680,420,000.00
  • SHO $910,264,000.00
  • Revenue This Year
  • AMRX $17.86
  • SHO N/A
  • Revenue Next Year
  • AMRX $3.90
  • SHO $9.28
  • P/E Ratio
  • AMRX N/A
  • SHO $16.30
  • Revenue Growth
  • AMRX 12.32
  • SHO N/A
  • 52 Week Low
  • AMRX $5.01
  • SHO $9.39
  • 52 Week High
  • AMRX $9.48
  • SHO $12.41
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 42.36
  • SHO 77.95
  • Support Level
  • AMRX $7.68
  • SHO $12.04
  • Resistance Level
  • AMRX $8.18
  • SHO $12.41
  • Average True Range (ATR)
  • AMRX 0.29
  • SHO 0.21
  • MACD
  • AMRX -0.04
  • SHO 0.05
  • Stochastic Oscillator
  • AMRX 25.41
  • SHO 94.86

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. Sunstone's sole source of income is hotel revenue from its hotel ownership segment.

Share on Social Networks: